Barriers and facilitators for physical activity in people living with chronic pain: a systematic review and combined analysis.

ABSTRACT: Chronic pain is a prevalent and complex health issue associated with physical, emotional, and social consequences. Management of pain is multifactorial and challenging; however, physical activity (PA) has consistently been shown to be beneficial. Despite this, PA levels among people with chronic pain are low. This study aimed to identify facilitators and barriers to PA among adults with chronic pain and analyse these using the structure of a validated behaviour change model: the capability, opportunity, and motivation behaviour change model (COM-B). We performed a systematic review of 6 databases and subsequent combined analysis including peer-reviewed primary research published in English up to November 15, 2023. Search terms consisted of 3 components: pain, PA, and facilitators/barriers. Quality appraisal of studies was conducted using appropriate tools. The systematic search yielded 40 eligible studies with a total of 2164 participants. The studies represented various chronic pain conditions, locations, and study designs. The key barriers to engagement in PA were the impact of pain severity, comorbidities, lack of knowledge about PA benefits, and time constraints. Key facilitators were a personalised approach, social support, and awareness of the benefits. The findings were categorised according to the COM-B model, allowing for the identification of modifiable factors. Person-centred approaches, education, and accessible environments were identified as important aspects to consider for successful PA promotion among people with chronic pain. Utilising the factors identified in the COM-B model is crucial for successful future interventions to increasing PA uptake and adherence in this population.

High-density thermal sensitivity maps of the body of people with multiple sclerosis: Implications for inclusive personal comfort systems.

Inclusive thermal comfort solutions should accommodate the need of clinical groups such as people with Multiple Sclerosis (pwMS), who experience abnormal thermal sensitivity. The aim of this study was to develop high-density body maps of temperature sensitivity in pwMS to inform the design of patient-centred personal comfort systems. Fourteen pwMS (6 M/8 F; 48.6 ± 10.0 y) and 13 healthy individuals (CTR; 5 M/8 F; 47.8 ± 10.4) underwent a quantitative sensory test in a thermoneutral environment, during which they rated their local thermal sensations arising from the application of warm (39°C) and cold (27°C) stimuli to 115 bilateral body sites across the face, torso, upper and lower limbs. We used a z-transformation to create maps of hypo- and hyper-sensitivity for each individual MS participant using normative CTR data. We found that 50% of pwMS (N = 7/14) presented a loss of cold sensitivity over the upper limb, and a loss of warm sensitivity over the feet. Furthermore, 36% of pwMS (N = 5) presented warm hyper-sensitivity over the upper limb. Finally, cold sensitivity loss and warm sensitivity gain were more evenly distributed and affected a greater proportion of skin sites in MS (i.e. cold hypo-sensitivity = 44% of tested sites; warm hyper-sensitivity = 14%) than warm sensitivity loss (i.e. 10%), which was more focused on sites such as the feet. Our findings highlight the need to consider "thermosensory corrective power" when designing personal comfort systems, to accommodate either thermosensory loss or gain in pwMS. Our approach to clinical body mapping may support this process and help meeting the unique thermal needs of vulnerable individuals.

Body temperatures, thermal comfort, and neuropsychological responses to air temperatures ranging between 12°C and 39°C in people with Multiple Sclerosis.

The negative effects of thermal stress on Multiple Sclerosis (MS)' symptoms have long been known. However, the underlying mechanisms of MS heat and cold intolerance remain unclear. The aim of this study was to evaluate body temperatures, thermal comfort, and neuropsychological responses to air temperatures between 12 and 39 °C in people with MS compared to healthy controls (CTR). Twelve MS (5 males/7 females; age: 48.3 ± 10.8 years; EDSS range: 1-7) and 11 CTR participants (4 males /7 females; age: 47.5 ± 11.3 years) underwent two 50-min trials in a climatic chamber. Air temperature was ramped from 24 °C to either 39 °C (HEAT) or 12 °C (COLD) and we continuously monitored participants' mean skin (Tsk) and rectal temperatures (Trec), heart rate and mean arterial pressure. We recorded participants' self-reported thermal sensation and comfort, mental and physical fatigue, and we assessed their cognitive performance (information processing). Changes in mean Tsk and Trec did not differ between MS and CTR neither during HEAT nor COLD. However, at the end of the HEAT trial, 83% of MS participants and 36% of CTR participants reported being "uncomfortable". Furthermore, self-reports of mental and physical fatigue increased significantly in MS but not CTR (p < 0.05), during both HEAT and COLD. Information processing was lower in MS vs. CTR (p < 0.05); yet this cognitive impairment was not exacerbated by HEAT nor COLD (p > 0.05). Our findings indicate that neuropsychological factors (i.e. discomfort and fatigue) could contribute to MS heat and cold intolerance in the absence of deficits in the control of body temperature.

Regional skin wetness perception and its modulation by warm and cold whole body skin temperatures in people with multiple sclerosis.

Skin wetness sensing is important for thermal stress resilience. Individuals with multiple sclerosis (MS) present greater vulnerability to thermal stress; yet, it is unclear whether they present wetness-sensing abnormalities. We investigated the effects of MS on wetness sensing and their modulation with changes in mean skin temperature (Tsk). Twelve participants with MS [5 males (M)/7 females (F); 48.3 ± 10.8 yr; Expanded Disability Status Scale (EDSS) range: 1-7] and 11 healthy controls (4 M/7 F; 47.5 ± 11.3 yr) undertook three trials, during which they performed a quantitative sensory test with either a thermoneutral (30.9°C), warm (34.8°C), or cold (26.5°C) mean Tsk. Participants reported on visual analog scales local wetness perceptions arising from the static and dynamic application of a cold-, neutral-, and warm-wet probe (1.32 cm2; water content: 0.8 mL), to the index finger pad, forearm, and forehead. Data were analyzed for the group-level effect of MS, as well as for its individual variability. Our results indicated that MS did not alter skin wetness sensitivity at a group level, across the skin sites and temperature tested, neither under normothermia nor under conditions of shifted thermal state. However, when taking an individualized approach to profiling wetness-sensing abnormalities in MS, we found that 3 of the 12 participants with MS (i.e., 25% of the sample) presented a reduced wetness sensitivity on multiple skin sites and to different wet stimuli (i.e., cold, neutral, and warm wet). We conclude that some individuals with MS may possess reduced wetness sensitivity; however, this sensory symptom may vary greatly at an individual level. Larger-scale studies are warranted to characterize the mechanisms underlying such individual variability.

Heat and cold sensitivity in multiple sclerosis: A patient-centred perspective on triggers, symptoms, and thermal resilience practices.

BACKGROUND: The negative effects of heat and cold on Multiple Sclerosis (MS) have been known for ∼100 years. Yet, we lack patient-centred investigations on temperature sensitivity in persons with MS (pwMS). OBJECTIVES: To evaluate triggers, symptoms, and thermal resilience practices of temperature sensitivity pwMS via a dedicated survey. METHODS: 757 pwMS completed an online survey assessing the subjective experience of temperature sensitivity. We performed descriptive statistics and regression analyses to evaluate association between individual factors and susceptibility/resilience to thermal stress. RESULTS: Temperature sensitivity varied significantly in pwMS, with 58% of participants being heat sensitive only; 29% heat and cold sensitive; and 13% cold sensitive only (p<0.001). Yet, all pwMS: i) experienced hot and cold days as primary triggers; ii) reported fatigue as the most common worsening symptom, impacting walking and concentration; iii) used air conditioning and changes in clothing insulation as primary thermal resilience practices. Furthermore, certain individual factors (i.e. age, level of motor disability, experience of fatigue) were predictive of greater susceptibility to certain triggers (e.g. hot days) and symptoms (e.g. fatigue). CONCLUSION: Patient-centred evidence on the impact of and response to temperature sensitivity could play an important role in the development of individualised healthcare plans for temperature-sensitive pwMS.

A patient-centred evaluation of phantom skin wetness as a sensory symptom in people with multiple sclerosis.

BACKGROUND: A noticeable but unknown proportion of people with multiple sclerosis (pwMS) report the sudden experience of wetness on a dry skin site, i.e., phantom wetness. Yet, we lack patient-centred investigations on the prevalence and subjective experience of this uncomfortable symptom. OBJECTIVES: To assess the prevalence of phantom wetness in pwMS, its association with individual factors, and subjective experience. METHODS: 757 pwMS completed an online survey assessing the frequency and subjective experience of phantom wetness. We calculated descriptive statistics and odd ratios and performed a thematic analysis to extract a patient-centred description of phantom wetness. RESULTS: 220 participants reported experiencing phantom wetness (29%). Females and those affected by Relapsing Remitting (RR) MS were 2.17 [1.39, 3.34] (p<0.001) and 1.73 [1.23, 2.40] (p = 0.001) times as likely to experience phantom wetness as males and those not affected by RR MS, respectively. The thematic analysis indicated phantom wetness is more often experienced as water trickling on the skin of the lower limb. CONCLUSION: Phantom wetness is a paraesthesia occurring in almost a third of the sample surveyed. Clinicians are encouraged to discuss with pwMS to validate their experience as a genuine symptom. Using the patient-generated language we report may help facilitate such conversations.

Individualized analysis of skin thermosensory thresholds and sensitivity in heat-sensitive people with multiple sclerosis.

We investigated whether and how multiple sclerosis (MS) alters thresholds for perceiving increases and decreases in local skin temperature, as well as the sensitivity to progressively greater temperature stimuli, amongst heat-sensitive people with MS. Eleven MS patients (5 M/6 F; 51.1 ± 8.6 y, EDSS 5.7 ± 1.9) and 11 healthy controls (CTR; 7 M/4 F; 50.3 ± 9.0 y) performed warm and cold threshold tests on a hairy skin site, on both sides of the body. They also underwent a thermosensitivity test where they rated (visual analogue scale) perceived magnitude of 4 local skin stimuli (i.e. 22, 26, 34, 38°C). Individual thresholds and slopes of linear regression for thermosensitivity were z-transformed for each MS patient, and used to determine individual thermosensory abnormalities. When considering both threshold and thermosensitivity, six out of our 11 heat-sensitive patients (54.5%) exhibited skin thermosensory abnormalities. Those abnormalities varied amongst patients in terms of type (threshold vs. thermosensitivity), quality (warm vs. cold), location (left vs. right side of the body) and extent. Each of those six patients presented unique thermosensory profiles. While some patients experienced thermosensory loss in both thresholds and sensitivity and on both sides of the body, others experienced cold thermosensory loss on one side of the body only. The observed individual variability in thermosensory function among heat-sensitive MS patients highlight the need for a patient-centered approach to assessing thermosensory dysfunction and its potential implications for heat stress vulnerability in this patient group.

Maintaining everyday life praxis in the time of COVID-19 pandemic measures (ELP-COVID-19 survey).

BACKGROUND: The extreme social circumstances caused by declared COVID-19 pandemic deeply intervene people's everyday life and should not be neglected but seen through the view of social reality pinpointing the 'ordinary' people. In this article, authors explored basic segments of everyday and their subjective perception to what extent sleeping habits, physical inactivity, physical activity, nutritional habits and smoking have changed. METHODS: The online survey was conducted in nine European countries (Bosnia and Herzegovina, Croatia, Greece, Kosovo*, Italy, Serbia, Slovakia, Slovenia and Spain) in 4108 participants, aged 15-82 years. The survey took place 30-40 days after World Health Organization declared COVID-19 pandemic state, from 15 April to 3 May 2020. RESULTS: The results have shown 30 min longer sleeping time, 50% longer physical inactivity time, 65% longer screen time, 43% shorter walking time, 24% shorter sport time and 37% longer physical work time. Additionally, body mass gains (0.3 kg) could be explained in 20.6% with meals sizes, unhealthy food consumption, screen time and sport time. Further, respondents reported more regular meals (44%) and healthier meals with less alcohol consumption and less smoking, which have been positive outcomes of home confinement. CONCLUSION: The findings draw attention to negative changes in everyday praxis (inactivity, body mass gain) after such a short period. Because of possible risk to population's health (especially of countries such as Italy and Spain with serious threat and more stringent measures), findings enable development of recommendations for maintaining healthy lifestyle habits with minimal negative health consequences in similar pandemic circumstances.

Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms.

Multiple sclerosis (MS) is an autoimmune neurodegenerative disease characterized by demyelination of the central nervous system (CNS). The exact cause of MS is still unknown; yet its incidence and prevalence rates are growing worldwide, making MS a significant public health challenge. The heterogeneous distribution of demyelination within and between MS patients translates in a complex and varied array of autonomic, motor, sensory and cognitive symptoms. Yet a unique aspect of MS is the highly prevalent (60-80%) temperature sensitivity of its sufferers, where neurological symptoms are temporarily exacerbated by environmental- or exercise-induced increases (or decreases) in body temperature. MS temperature sensitivity is primarily driven by temperature-dependent slowing or blocking of neural conduction within the CNS due to changes in internal (core) temperature; yet changes in skin temperature could also contribute to symptom exacerbation (e.g. during sunlight and warm ambient exposure). The impact of temperature sensitivity, and particularly of increases in core temperature, on autonomic (e.g. thermoregulatory/cardiovascular function) and motor symptoms (e.g. fatigue) is well described. However, less attention has been given to how increases (and decreases) in core and skin temperature affect sensory and cognitive symptoms. Furthermore, it remains uncertain whether changes in skin temperature alone could also trigger worsening of symptoms. Here we review the impact of temperature sensitivity on MS sensory and cognitive function and discuss additional factors (e.g. changes in skin temperature) that potentially contribute to temperature-induced worsening of symptoms in the absence of alteration in core temperature.